ArticleActa veterinaria Scandinavica2026
First molecularly confirmed case of canine thelaziosis due to Thelazia callipaeda infection in Estonia.
Article in Acta veterinaria Scandinavica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundThelazia callipaeda is a zoonotic vector-borne nematode primarily affecting carnivores, lagomorphs, and humans. Over the past decades, the parasite has expanded across Europe. This report presents the first molecularly confirmed case of canine thelaziosis in Estonia. The findings highlight the urgent need for increased awareness of T. callipaeda among veterinarians, human medical professionals, and pet owners, as this parasite poses an important public health concern. CASE PRESENTATION: A 6-year-old spayed female Swiss White Shepherd, with a recent travel history to several European countries, including the Baltic countries, Poland, the Czech Republic, Austria, Italy, Switzerland, Liechtenstein, Germany, and Sweden, was presented to the Small Animal Clinic of Estonian University of Life Sciences with unilateral ocular discharge and hyperaemia. Ophthalmic examination revealed the presence of motile, threadlike nematodes in the left eye. The treatment involved manual removal of nematodes and oral administration of milbemycin oxime/praziquantel twice with 1 week interval in combination with topical lubrication. Follow-up examinations revealed significant improvement in ocular health, with no further signs of infection. The nematodes were identified as T. callipaeda based on molecular analysis.
conclusionsThis case highlights the importance of obtaining a comprehensive travel history in veterinary ophthalmology and emphasizes the emerging risk of T. callipaeda in non-endemic regions, especially with increased pet travel. Early diagnosis and appropriate treatment are crucial for successful management. Preventive measures, such as antiparasitic treatment before and during travel, are essential to reduce the risk of transmission. The growing concern of T. callipaeda spread is further supported by previous ecological niche model predictions, suggesting the potential for the vector's geographic expansion across Europe.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.